Definitive Healthcare Corp. (NASDAQ:DH) Receives $36.55 Consensus Target Price from Analysts

Definitive Healthcare Corp. (NASDAQ:DH – Get Rating) has been given an average rating of “Hold” by the fourteen brokerages that are covering the company, MarketBeat reports. Seven research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average twelve-month target price among brokers that have covered the stock in the last year is $37.00.

Several analysts have recently weighed in on the stock. Canaccord Genuity Group raised shares of Definitive Healthcare from a “hold” rating to a “buy” rating and lowered their target price for the company from $46.00 to $28.00 in a report on Thursday, February 24th. Credit Suisse Group decreased their price objective on shares of Definitive Healthcare from $30.00 to $24.00 and set a “neutral” rating on the stock in a report on Thursday, February 24th. Zacks Investment Research raised shares of Definitive Healthcare from a “sell” rating to a “hold” rating in a report on Wednesday, April 6th. Morgan Stanley raised shares of Definitive Healthcare from an “equal weight” rating to an “overweight” rating and decreased their price objective for the stock from $46.00 to $40.00 in a report on Thursday, December 16th. Finally, Canaccord Genuity Group raised shares of Definitive Healthcare from a “hold” rating to a “buy” rating in a report on Thursday, February 24th.

In other Definitive Healthcare news, CFO Richard Douglas Booth bought 2,374 shares of Definitive Healthcare stock in a transaction dated Thursday, March 3rd. The stock was bought at an average cost of $21.06 per share, for a total transaction of $49,996.44. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. increased its stake in Definitive Healthcare by 50.4% in the 4th quarter. BlackRock Inc. now owns 2,256,587 shares of the company’s stock worth $61,672,000 after purchasing an additional 756,587 shares in the last quarter. Conestoga Capital Advisors LLC boosted its position in Definitive Healthcare by 1,854.3% during the 4th quarter. Conestoga Capital Advisors LLC now owns 1,959,623 shares of the company’s stock worth $53,556,000 after acquiring an additional 1,859,350 shares during the period. JPMorgan Chase & Co. boosted its position in Definitive Healthcare by 431.8% during the 4th quarter. JPMorgan Chase & Co. now owns 1,600,689 shares of the company’s stock worth $43,747,000 after acquiring an additional 1,299,679 shares during the period. Capital World Investors acquired a new stake in Definitive Healthcare during the 3rd quarter worth about $64,245,000. Finally, Jennison Associates LLC boosted its position in Definitive Healthcare by 258.5% during the 4th quarter. Jennison Associates LLC now owns 1,116,517 shares of the company’s stock worth $30,514,000 after acquiring an additional 805,036 shares during the period. 97.34% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NASDAQ:DH traded down $1.08 during midday trading on Monday, hitting $24.90. The stock had a trading volume of 256,903 shares, compared to its average volume of 620,671. The stock has a 50 day moving average price of $23.08 and a two-hundred day moving average price of $28.99. The company has a quick ratio of 3.77, a current ratio of 3.77 and a debt-to-equity ratio of 0.18. Definitive Healthcare has a 1 year low of $18.15 and a 1 year high of $50.30.

Definitive Healthcare (NASDAQ:DH – Get Rating) last issued its earnings results on Wednesday, February 23rd. The company reported $0.04 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.02 by $0.02. The firm had revenue of $46.31 million during the quarter, compared to analysts’ expectations of $44.78 million. As a group, equities research analysts predict that Definitive Healthcare will post 0.11 earnings per share for the current year.

About Definitive Healthcare (Get Rating)

Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution.

Further Reading